Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
Rocket Pharmaceuticals, Inc. (RCKT)
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
rocketpharma.com
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (Nasdaq:RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announces participation at the following upcoming industry conferences: Cowen and Company 39th Annual Health Care Conference Kinnari Patel, Pharm.D., MBA, COO, Jonathan Schwartz, M.D., CMO, and Claudine Prowse, Ph.D., SVP, Strategy, and IRO will participate in a fireside chat on Tuesday, March 12, 2019, at 10:40 a.m. Eastern Time. Alliance for Regenerative Medicine Cell & Gene Investor Day Gaurav Shah, M.D., President and CEO, is scheduled to present on Thursday, March 21, 2019, at 9:55 a.m. Eastern Time. American College of Cardiology 2019 Annual Meeting Three abstracts from the Danon disease p
Show less
Read more
Impact Snapshot
Event Time:
RCKT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCKT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCKT alerts
High impacting Rocket Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RCKT
News
- Why Is Rocket Pharmaceuticals (RCKT) Down 13.6% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team [Yahoo! Finance]Yahoo! Finance
- Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership TeamBusiness Wire
- Rocket Pharmaceuticals' Promising Path In Gene Therapy [Seeking Alpha]Seeking Alpha
- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at UBS Group AG from $56.00 to $54.00. They now have a "buy" rating on the stock.MarketBeat
RCKT
Earnings
- 2/26/24 - Beat
RCKT
Sec Filings
- 3/25/24 - Form 4
- 3/25/24 - Form 4
- 3/21/24 - Form 144
- RCKT's page on the SEC website